Latest Schedule 13G passive stakes

Highbridge Capital Management, LLC has reported beneficial ownership of 1,092,500 Ordinary Shares, representing 6.8% of the outstanding shares of GalaxyEdge Acquisition Corp.

Key Group Long Term Investments LP and Sunil Jagwani have filed an amendment to their Schedule 13G, reporting beneficial ownership of 3.2% of Chord Energy Corp. common stock.

Highbridge Capital Management, LLC has reported beneficial ownership of 7.3% of Maywood Acquisition Corp.'s Class A Ordinary Shares, totaling 764,885 shares.

Highbridge Capital Management, LLC has filed a Schedule 13G amendment indicating zero beneficial ownership of Factorial Energy Inc. Series A Common Stock as of June 30, 2026.

Highbridge Capital Management, LLC has reported beneficial ownership of 1,638,750 Class A Ordinary Shares, representing 8.8% of the outstanding shares in JAB Acquisition Corp I.

Key Group Long Term Investments LP and Sunil Jagwani have filed an amended Schedule 13G, reporting beneficial ownership of 12.8% of Methanex Corporation's common shares.

Highbridge Capital Management, LLC has reported a complete divestment of its Class A Common Stock in Bel Fuse Inc., holding zero shares beneficially.

Highbridge Capital Management, LLC has reported beneficial ownership of 8.1% of TOYO Co., Ltd's ordinary shares, including shares issuable upon warrant exercise.

Highbridge Capital Management, LLC has filed a Schedule 13G, reporting beneficial ownership of 78 shares of Aspire Biopharma Holdings, Inc. common stock, representing 0.0% of the class.

Key Group Long Term Investments LP and Sunil Jagwani have jointly reported a 7.0% beneficial ownership of Peabody Energy Corporation's common stock.

Cooper Creek Partners Management LLC has reported a 9.6% beneficial ownership of WW International, Inc. common stock as of June 30, 2026.

Highbridge Capital Management, LLC has reported beneficial ownership of 9.9% of Sharplink, Inc.'s common stock, including shares issuable upon warrant exercise, subject to a 9.99% ownership blocker.

Philosophy Capital Management LLC, Philosophy Capital Partners, LP, and Jacob Rubin have jointly filed a Schedule 13G, reporting beneficial ownership of 17.0% and 6.4% of Nine Energy Service, Inc. common stock, respectively, subject to a voting agreement.

Tenor Capital Management Company, L.P., Tenor Opportunity Master Fund, Ltd., and Robin Shah have jointly filed a Schedule 13G, reporting no beneficial ownership of A Paradise Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Philosophy Capital Management LLC and Jacob Rubin have jointly filed a Schedule 13G, reporting beneficial ownership of 2,906,764 shares, representing 5.4% of Hudson Pacific Properties, Inc. common stock.

Earnest Partners, LLC has filed a Schedule 13G, disclosing beneficial ownership of 6.5% of Wolverine World Wide, Inc.'s common stock as of June 30, 2026.

Armada Acquisition Corp. II files an amendment to Schedule 13G, detailing ownership stakes held by Tenor Capital Management Company, L.P., Tenor Opportunity Master Fund, Ltd., and Robin Shah.

Cooper Creek Partners Management LLC has filed a Schedule 13G, disclosing beneficial ownership of 13,615,302 shares, representing 7.3% of Ferroglobe PLC's common stock.

Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang have reported a change in their beneficial ownership of Viridian Therapeutics, Inc. common stock, now holding 5.7% of the class.

Several key entities and individuals associated with Castlelake have reported zero beneficial ownership of Oportun Financial Corp common stock, signaling a complete exit.

Several QS-affiliated entities have reported their beneficial ownership of BBB Foods Inc. Class A Common Shares, with holdings converted from Class C shares.

AuGC BioFund LP, AuGC Partners LLC, and Evan Markegard have jointly reported beneficial ownership of 4.7% of Palatin Technologies Inc. common stock.

Kynam Capital Management, LP, along with its affiliates, has reported beneficial ownership of 4.01% of Vera Therapeutics, Inc.'s Class A common stock as of June 30, 2026.

Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen have jointly filed a Schedule 13G, reporting beneficial ownership of 5.3% of Core Scientific, Inc. common stock as of June 30, 2026.

Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang have reported beneficial ownership of 9.96% of CytomX Therapeutics' common stock as of June 30, 2026.

SilverArc Capital Management, LLC and Devesh Gandhi have reported beneficial ownership of 9.99% of Cellectar Biosciences Inc.'s Class A Common Stock, primarily through exercisable warrants.

First Trust Merger Arbitrage Fund and affiliated entities report holding zero shares of GP-Act III Acquisition Corp. Class A Ordinary Shares as of June 30, 2026.

Kynam Capital Management, LP, along with its GP and principal Yue Tang, has reported a 6.78% beneficial ownership of Celldex Therapeutics, Inc. common stock as of June 30, 2026.

Laurence W. Lytton and the Lytton-Kambara Foundation have jointly filed an update regarding their beneficial ownership of Aytu BioPharma, Inc. common stock, maintaining their holdings below the 5% threshold.

Earnest Partners, LLC has updated its Schedule 13G filing, reporting beneficial ownership of 6.0% of Sabre Corp. common stock as of June 30, 2026.